NetworkNewsBreaks – Healthy Extracts Inc. (HYEX)
Post# of 126
(Total Views: 547)
Posted On: 04/29/2021 3:58:45 PM
NetworkNewsBreaks – Healthy Extracts Inc. (HYEX) Continues to Strengthen Position in Plant-Based Health Industry
Healthy Extracts (OTCQB: HYEX) is committed to growth and has aligned its operations to focus on the plant-based health industry. Reflecting this focus, HYEX changed its name from Grey Cloak Tech to align with the company’s objectives and a “Live Life Young Again” strategy. “The company is making remarkable strides to strengthen its market positions in the plant-based health industry through its two key subsidiaries, the science-based BergaMet North America and Ultimate Brain Nutrients (‘UBN’),” reads a recent article. The company also achieved significant accomplishments in 2020, including a 71% increase in recorded gross revenue, despite the COVID pandemic, as well as elimination of all convertible debt. Further, net shareholder equity increased by $3.7 million. With regards to plant-based products, HYEX introduced “Clinical Immune, a clinically proven immunity product focusing on heart and respiratory health, while sales of the Fuel4Thought Brain Booster product are expected to begin in Q2 after completion of key clinical studies.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Healthy Extracts (OTCQB: HYEX) is committed to growth and has aligned its operations to focus on the plant-based health industry. Reflecting this focus, HYEX changed its name from Grey Cloak Tech to align with the company’s objectives and a “Live Life Young Again” strategy. “The company is making remarkable strides to strengthen its market positions in the plant-based health industry through its two key subsidiaries, the science-based BergaMet North America and Ultimate Brain Nutrients (‘UBN’),” reads a recent article. The company also achieved significant accomplishments in 2020, including a 71% increase in recorded gross revenue, despite the COVID pandemic, as well as elimination of all convertible debt. Further, net shareholder equity increased by $3.7 million. With regards to plant-based products, HYEX introduced “Clinical Immune, a clinically proven immunity product focusing on heart and respiratory health, while sales of the Fuel4Thought Brain Booster product are expected to begin in Q2 after completion of key clinical studies.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)